A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology

Area of Science:

• Immunology
• Cellular Biology
• Biotechnology

Background:

• Standard 51Chromium (Cr)-release assays for cellular cytotoxicity are effective but involve radioactive materials.
• There is a need for non-radioactive, reliable, and user-friendly methods to assess cell-mediated cytotoxicity.
• Existing assays may have limitations in terms of safety, variability, or data analysis.

Purpose of the Study:

• To develop and validate a novel fluorescent cellular cytotoxicity assay using Calcein acetoxymethyl (Calcein-AM).
• To establish this assay as a viable, non-radioactive alternative to the 51Cr-release assay.
• To demonstrate its utility in evaluating the lytic activity of various immune effector cells.

Main Methods:

• Target cells were labeled with the fluorescent dye Calcein acetoxymethyl (Calcein-AM).
• Labeled target cells were co-incubated with effector cells (cytotoxic T lymphocytes, lymphokine-activated killer cells, natural killer cells).
• FluoroQuench reagent was used to quench fluorescence from dead cells and media; viable cells were quantified using a fluorescent scanner.

Main Results:

• The Calcein-AM assay produced results comparable to the traditional 51Cr-release assay.
• The assay demonstrated reliable measurement of cell-mediated cytotoxicity with minimal variance between replicates.
• It successfully quantified the lytic activity of cytotoxic T lymphocyte (CTL) cultures, lymphokine-activated killer (LAK), and natural killer (NK) cell lines.

Conclusions:

• The Calcein-AM fluorescent assay is a simple, safe, and effective alternative to radioactive cytotoxicity assays.
• This method offers advantages including reduced radioactivity, consistent results, and potential for digital imaging and analysis.
• It provides a valuable tool for researchers studying immune cell functions and drug efficacy.